Member Info for goupplease

I think we will have a swing round .
With the split I think we will lead the states ,
It means more here .

That there are shares left .
It's a small float next week goes metal imho
Not many trading days left .
I was pleased to pick up some more

I said it before say it again Dr Muhunthan Thillai is going to play a big part here

Not reported ,great price 170

If the trial comes positive and passes this will go mental.
All the reports say patients need the treatment
There are plenty of shares left I just bought.
Bet it's not reported

BM03 Halifax sent all the info last week
its on my member history i posted it

Strong hold,
Lots bumping this up

If we could get : Dr Muhuthan Thillai on the full board he would be great .
He's got the knowledge

halifax info
1 New Accustem Sciences (Accustem) share for each Existing Tiziana Life Sciences (Tiziana) share held on the Ex-entitlement Date, 30th October 2020.

On 16th September 2020, Tiziana announced that following a strategic review of its clinical trial programs and core focus, the Company intends to demerge its StemPrintER and SPARE genomics-based personalised medicine business, Accustem, into a separate and independent listed Company.

The Demerger is subject to shareholder approval at the General Meeting to be held on 2nd October 2020.

Subsequently, the Demerger is expected to become effective on 30th October 2020. However, it is not yet known when the New Accustem shares will be received.

Following completion of the Demerger, it is not yet known when the New Accustem will be admitted to trading on the Official List of the London Stock Exchange (LSE). Please note that whilst the New Accustem shares will be reflected on your account, the shares will not listed on a recognised stock exchange and therefore you are not able to sell or otherwise trade the Accustem shares through our nominee service.

Unless you hold your shares in a ShareBuilder account, no fractions of shares will be issued. Any resulting cash entitlements will be dealt with in accordance with our Terms & Conditions.

Should you retain your holding in Tiziana we will notify you when the New Accustem shares have been credited to your account.

If you wish to find more information about the Demerger, please visit the Tiziana website, www.tizianalifesciences.com/

Will be history at the pace nfx have moved on a deal

The news flow, it's done brilliant

hes still hands on here and has a wealth of knowledge

dont discount a tie up with the good doctors mob.

just one down

views please

True but this company operating in years not months !

Reckoned we were near a deal in Q1 was total *ollocks for me ,

Sit on hands or sell,
I will be sitting on hands .
Seriously they should have sold

We held our nerve and slowly the wait is over ,
The years of training on nfx have paid off

nasdaq down1.15 %